Press "esc" to clear
Go to Advanced Search

Showing results

110 of 233

Article ID: 700447

Rare Antibodies Show Scientists How to Neutralize the Many Types of Ebola

Scripps Research Institute

Two new studies by scientists at Scripps Research are bringing Ebola virus’s weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not only for Ebola virus, but for other closely related pathogens as well.

12-Sep-2018 4:45 PM EDT

Article ID: 698671

New Research Pinpoints Pathways Ebola Virus Uses to Enter Cells

Texas Biomedical Research Institute

A new study at Texas Biomedical Research Institute is shedding light on the role of specific proteins that trigger a mechanism allowing Ebola virus to enter cells to establish replication.

8-Aug-2018 10:00 AM EDT

Article ID: 698593

Novel Vaccine Approach Proves Powerful Against Zika Virus

Ohio State University

A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.

6-Aug-2018 10:05 AM EDT

Article ID: 698417

Ebola Virus - Subject Matter Experts

Georgetown University Medical Center

WASHINGTON — Georgetown University professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include infectious disease control and treatment, vaccine development, clinical trials, global health security, and international health regulations. To schedule an interview, please contact Karen Teber at km463@georgetown.

1-Aug-2018 2:05 PM EDT

Article ID: 698263

Vanderbilt Team Finds Potent Antibodies Against Three Ebola Viruses

Vanderbilt University Medical Center

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

30-Jul-2018 3:15 PM EDT

Article ID: 696615

Proteins Found in Semen Increase the Spread of Ebola Virus Infection

Perelman School of Medicine at the University of Pennsylvania

Protein fragments, called amyloid fibrils, in human semen significantly increase Ebola virus infection and protect the virus against harsh environmental conditions such as heat and dehydration. Follow-up studies from the 2014 epidemic found that men can harbor the virus in their semen for at least 2.5 years, with the potential to transmit the virus sexually during that time. Targeting amyloids in semen may prevent a sexually transmitted spread of the Ebola virus.

25-Jun-2018 3:50 PM EDT

Showing results

110 of 233

Chat now!